Literature DB >> 10978388

Blood pressure and the susceptibility to renal damage after unilateral nephrectomy and L-NAME-induced hypertension in rats.

R P van Dokkum1, H J Jacob, A P Provoost.   

Abstract

BACKGROUND: Fawn-hooded hypertensive (FHH) rats carry several genes which determine the susceptibility to develop renal damage, while renal damage resistant August x Copenhagen Irish (ACI) rats do not. Kidneys from heterozygous (FHH x ACI) F(1) rats, appear to be largely, but not completely, protected after blood pressure elevation with N(omega)-nitro-L-arginine methyl ester (L-NAME). We examined the role of an increased haemodynamic burden on the development of renal damage combining unilateral nephrectomy (UNx)- and L-NAME-induced hypertension in F(1) and ACI rats. Additionally, we investigated whether a general toxic effect of L-NAME, independent from a blood pressure elevation, caused renal damage in F(1) rats in animals simultaneously treated with L-NAME and the ACE inhibitor lisinopril.
METHODS: Surgery was performed and L-NAME treatment (50 or 150 mg/l) was started at the age of 15 weeks. Systolic blood pressure (SBP) and urinary albumin excretion (UaV) were measured at 6 and 12 weeks post-UNx, followed by autopsy to determine the incidence of focal glomerulosclerosis (FGS). Using lisinopril (LIS) and L-NAME, another group of rats was evaluated at 12, 18, and 24 weeks after start of treatment.
RESULTS: At similar L-NAME intake, F, rats developed more severe hypertension and more UaV than ACI rats. The increase in UaV per mmHg increase in SBP was fivefold higher in F(1) compared with ACI rats. In F(1) rats, the increase in UaV per percentage incidence increase in FGS was three times higher. In LIS treated F(1) rats, no significant UaV or FGS was measured at low blood pressure levels, indicating that renal damage in hypertensive F(1) rats is not a direct effect of L-NAME, but the result of the high blood pressure or another action of the renin-angiotensin system.
CONCLUSION: We conclude that heterozygosity for the genes influencing the development of renal damage in the FHH strain increases the susceptibility of the kidney to develop damage after UNx combined with systemic hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978388     DOI: 10.1093/ndt/15.9.1337

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Temporal characterization of the development of renal injury in FHH rats and FHH.1BN congenic strains.

Authors:  Jan Michael Williams; Marilyn Burke; Jozef Lazar; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

Review 2.  The adducin saga: pleiotropic genomic targets for precision medicine in human hypertension-vascular, renal, and cognitive diseases.

Authors:  Ezekiel Gonzalez-Fernandez; Letao Fan; Shaoxun Wang; Yedan Liu; Wenjun Gao; Kirby N Thomas; Fan Fan; Richard J Roman
Journal:  Physiol Genomics       Date:  2021-12-03       Impact factor: 3.107

3.  Genetic basis of the impaired renal myogenic response in FHH rats.

Authors:  Marilyn Burke; Malikarjuna Pabbidi; Fan Fan; Ying Ge; Ruisheng Liu; Jan Michael Williams; Allison Sarkis; Jozef Lazar; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2012-12-05

4.  Renal effects of Mammea africana Sabine (Guttiferae) stem bark methanol/methylene chloride extract on L-NAME hypertensive rats.

Authors:  Elvine Pami Nguelefack-Mbuyo; Théophile Dimo; Télesphore Benoit Nguelefack; Alain Bertrand Dongmo; Pierre Kamtchouing; Albert Kamanyi
Journal:  Indian J Pharmacol       Date:  2010-08       Impact factor: 1.200

5.  Knockout of γ-Adducin Promotes NG-Nitro-L-Arginine-Methyl-Ester-Induced Hypertensive Renal Injury.

Authors:  Letao Fan; Wenjun Gao; Yedan Liu; Joshua R Jefferson; Fan Fan; Richard J Roman
Journal:  J Pharmacol Exp Ther       Date:  2021-01-07       Impact factor: 4.030

6.  Nephrocalcinosis in adolescent girl with medullary sponge kidney and mild hemihypertrophy: A case report.

Authors:  Monika Kusz; Beata Bieniaś; Anna Wieczorkiewicz-Płaza; Agnieszka Brodzisz; Paweł Wieczorek; Przemysław Sikora
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.